The PALS teaching of SVT (Supraventricular Tachycardia) is to revert to the sinus rhythm as early as possible, to prevent the onset of CHF or it's progression. A patient, already presenting in the cardiogenic shock (pale, lethargy, PR 180 /mt.) due to the 2nd episode of SVT has no time for vagal maneuvers and must be given Adenosine by a rapid push method (1st dose 0.1mg/kg up to 6 mg and subsequent 0.2 mg/kg up to 12mg). Meanwhile, the preparations must be done for the synchronised cardioversion (1st dose 0.05 -1J/Kg) and subsequent dose of 2 J/Kg). If the cardiac functions improve, the need for other means of treating shock and mechanical ventilation would logically decrease. These methods are so specific that if they fail to terminate the
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In the present case management, there is no mention of using adenosine or cardioversion. In both the episodes of SVT, there was heavy dependence on either Amiodarone or the secondary measures to combat a shock. 
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Prolonged Sedation Following Administration of Oral Midazolam
Midazolam is a commonly used drug for procedural sedation in children due to its rapid onset, short duration of action and hemodynamic stability, which may be associated with improved patient acceptance. It is also associated with shorter recovery time and minimal risk of vomiting and respiratory depression, making it the drug of choice for conscious sedation in pediatric patients. We report an unusual drug interaction between midazolam and azithromycin leading to prolonged sedation in a child.
A 2-year-old male child presented with laceration in the thigh after falling down from bicycle. There was no evidence of head injury or injury to any internal organs. X-ray of thigh did not reveal any fractures. Suturing was planned after giving local anesthesia. One milligram of parenteral preparation of midazolam (0.1 mg/kg) was given orally as a premedication for sedation. Procedure was successfully completed. The child continued to remain sedated even after the procedure. The child was monitored in intensive care overnight. He was hemodynamically stable throughout and there was no evidence of respiratory depression. Though the child was arousable, he slipped into sleep immediately after that. Child regained consciousness the next day, but remained drowsy. We could not identify the cause of this unexplained prolonged drowsiness. Detailed history revealed that the child had fever for 3 days for which he had been prescribed oral azithromycin by a practitioner. The dose of 200 mg once daily (20 mg/kg) was given as syrup formulation for 3 days before oral midazolam was given. The patient was discharged the next day and was normal at follow up for suture removal.
Literature search revealed the possibility of drug interaction between midazolam and macrolides, erthyromycin in particular, an inhibitor of CYP3A which is a cytochrome P450 isoform responsible for midazolam hydroxylation [1] . There are reports of drug interaction between erythromycin and oral midazolam, leading to prolonged sedation [2]. Such interaction is also possible with azithromycin [1]. Azithromycin has not been found to increase the plasma concentrations of oral midazolam in few studies [3, 4] , though both these studies were done on healthy adult volunteers and not in children. The chance of drug interaction is minimal with intravenous midazolam since it bypasses the altered presystemic metabolism and its pharmacokinetics is not affected to the same extent as after oral administration [5] . As azithromycin is commonly prescribed in pediatric patients, physicians should be aware of this possible drug interaction with oral midazolam. If midazolam has to be
